Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36)

Journal of Biological Chemistry

Volumn 287, Issue 10, 2012, Pages 7169-7181

  Chaudhri, Reyhaan A ^a,b   Olivares Navarrete, Rene ^c   Cuenca, Natalia ^c   Hadadi, Agreen ^a   Boyan, Barbara D ^a,b,c   Schwartz, Zvi ^c  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY   (United States)

^c Emory University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-APOPTOTIC EFFECTS; BREAST CANCER; BREAST CANCER CELLS; CANCER CELLS; CELL VIABILITY; DELETERIOUS EFFECTS; DNA FRAGMENTATION; DOWNSTREAM EFFECTS; ESTROGEN RECEPTOR; IN-VITRO ASSAYS; INVASIVENESS; METASTATIC POTENTIAL; MULTIPLE CELLS; PRO-APOPTOTIC EFFECTS; PROTEIN KINASE C; QUANTITATIVE RT-PCR; SPLICE VARIANTS; TUMORIGENESIS; TUMORIGENICITY; WESTERN BLOTS;

BROMINE COMPOUNDS; CELL CULTURE; CELL MEMBRANES; CELL PROLIFERATION; PATHOLOGY; POLYMERASE CHAIN REACTION; SIGNALING;

CELL DEATH;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA 36; MESSENGER RNA; PROTEIN KINASE C; THYMIDINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENICITY; CELL ASSAY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN ACTIVITY; ESTROGEN RECEPTOR ALPHA 36 GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HORMONE DETERMINATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; METASTASIS; MOLECULAR PATHOLOGY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GENE; WESTERN BLOTTING;

ALTERNATIVE SPLICING; ANIMALS; ANTIBODIES, NEUTRALIZING; APOPTOSIS; BREAST NEOPLASMS; CELL MEMBRANE; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HELA CELLS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEIN ISOFORMS; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 84857756831     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.292946     Document Type: Article

References (49)

1. Kampa, M., Pelekanou, V., and Castanas, E. (2008) Membrane-initiated steroid action in breast and prostate cancer. Steroids 73, 953-960
2. DeNardo, D. G., Cuba, V. L., Kim, H., Wu, K., Lee, A. V., and Brown, P. H. (2007) Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth. Mol. Cell. Endocrinol. 277, 13-25 (Pubitemid 47488609)
3. Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., and Narod, S. A. (2007) Triple-negative breast cancer. Clinical features and patterns of recurrence. Clin. Cancer Res. 13, 4429-4434 (Pubitemid 47219710)
4. Fernö, M., Baldetorp, B., Bendahl, P. O., Borg, A., Ewers, S. B., Olsson, H., Rydén, S., Sigurdsson, H., and Killander, D. (1995) Recurrence-free survival in breast cancer improved by adjuvant tamoxifen. Especially for progesterone receptor-positive tumors with a high proliferation. Breast Cancer Res. Treat. 36, 23-34
5. Madsen, M. W., Reiter, B. E., and Lykkesfeldt, A. E. (1995) Differential expression of estrogen receptor mRNA splice variants in the tamoxifen-resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line. Mol. Cell. Endocrinol. 109, 197-207
6. Poola, I., Koduri, S., Chatra, S., and Clarke, R. (2000) Identification of 20 alternatively spliced estrogen receptor α mRNAsin breast cancer cell lines and tumors using splice targeted primer approach. J. Steroid Biochem. Mol. Biol. 72, 249-258 (Pubitemid 30261529)
7. Levin, E. R. (1999) Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol. Metab. 10, 374-377
8. Sylvia, V. L., Boyan, B. D., Dean, D. D., and Schwartz, Z. (2000) The membrane effects of 17β-estradiol on chondrocyte phenotypic expression are mediated by activation of protein kinase C through phospholipase C and G-proteins. J. Steroid. Biochem. Mol. Biol. 73, 211-224
9. Song, R. X., Zhang, Z., and Santen, R. J. (2005) Estrogen rapid action via protein complex formation involving ERα and Src. Trends Endocrinol. Metab. 16, 347-353 (Pubitemid 41338739)
10. Kim, K. H., and Bender, J. R. (2009) Membrane-initiated actions of estrogen on the endothelium. Mol. Cell. Endocrinol. 308, 3-8
11. Schwartz, Z., Sylvia, V. L., Guinee, T., Dean, D. D., and Boyan, B. D. (2002) Tamoxifen elicits its anti-estrogen effects in growth plate chondrocytes by inhibiting protein kinase C. J. Steroid Biochem. Mol. Biol. 80, 401-410 (Pubitemid 34442602)
12. McMillan, J., Fatehi-Sedeh, S., Sylvia, V. L., Bingham, V., Zhong, M., Boyan, B. D., and Schwartz, Z. (2006) Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways. Biochim. Biophys. Acta 1763, 381-392
13. Boyan, B. D., Sylvia, V. L., Frambach, T., Lohmann, C. H., Dietl, J., Dean, D. D., and Schwartz, Z. (2003) Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen. Endocrinology 144, 1812-1824 (Pubitemid 36543319)
14. Wang, Z., Zhang, X., Shen, P., Loggie, B. W., Chang, Y., and Deuel, T. F. (2005) Identification, cloning, and expression of human estrogen receptor- α36, a novel variant of human estrogen receptor-α66. Biochem. Biophys. Res. Commun. 336, 1023-1027 (Pubitemid 41383424)
15. Lin, S. L., Yan, L. Y., Liang, X. W., Wang, Z. B., Wang, Z. Y., Qiao, J., Schatten, H., and Sun, Q. Y. (2009) A novel variant of ER-α, ER-α36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells. Reprod. Biol. Endocrinol. 7, 102
16. Wang, Z., Zhang, X., Shen, P., Loggie, B. W., Chang, Y., and Deuel, T. F. (2006) A variant of estrogen receptor-α, hER-α36. Transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 9063-9068 (Pubitemid 43902533)
17. Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., and Prossnitz, E. R. (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307, 1625-1630 (Pubitemid 40354745)
18. Kang, L., Zhang, X., Xie, Y., Tu, Y., Wang, D., Liu, Z., and Wang, Z. Y. (2010) Involvement of estrogen receptor variant ER-α36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol. 24, 709-721
19. Hu, P., Kinyamu, H. K., Wang, L., Martin, J., Archer, T. K., and Teng, C. (2008) Estrogen induces estrogen-related receptor α gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells. J. Biol. Chem. 283, 6752-6763
20. Touitou, I., Mathieu, M., and Rochefort, H. (1990) Stable transfection of the estrogen receptor cDNA into HeLa cells induces estrogen responsiveness of endogenous cathepsin D gene but not of cell growth. Biochem. Biophys. Res. Commun. 169, 109-115 (Pubitemid 20180999)
21. Kahlert, S., Nuedling, S., van Eickels, M., Vetter, H., Meyer, R., and Grohe, C. (2000) Estrogen receptor α rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 275, 18447-18453 (Pubitemid 30414803)
22. Smart, E. J., Ying, Y. S., Mineo, C., and Anderson, R. G. (1995)A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc. Natl. Acad. Sci. U.S.A. 92, 10104-10108
23. 2D3-dependent PKC signaling in chondrocytes and osteoblasts. Steroids 71, 286-290
24. 2D3 in chondrogenic ATDC5 cells. J. Cell. Biochem. 107, 155-162
25. Razandi, M., Pedram, A., and Levin, E. R. (2000) Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol. Endocrinol. 14, 1434-1447
26. Sui, M., Huang, Y., Park, B. H., Davidson, N. E., and Fan, W. (2007) Estrogen receptor α mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death. Cancer Res. 67, 5337-5344 (Pubitemid 46997273)
27. Zhong, M., Carney, D. H., Ryaby, J. T., Schwartz, Z., and Boyan, B. D. (2009) Inhibition of phosphate-induced apoptosis in resting zone chondrocytes by thrombin peptide 508. Cells Tissues Organs 189, 56-59
28. Akhtari, M., Mansuri, J., Newman, K. A., Guise, T. M., and Seth, P. (2008) Biology of breast cancer bone metastasis. Cancer Biol. Ther. 7, 3-9
29. Rose, A. A., and Siegel, P. M. (2006) Breast cancer-derived factors facilitate osteolytic bone metastasis. Bull. Cancer 93, 931-943 (Pubitemid 44520875)
30. Nakayama, T., Mutsuga, N., and Tosato, G. (2007) FGF2 post-transcriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc. Blood 109, 1363-1372 (Pubitemid 46239566)
31. Kousidou, O. Ch., Berdiaki, A., Kletsas, D., Zafiropoulos, A., Theocharis, A. D., Tzanakakis, G. N., and Karamanos, N. K. (2008) Estradiol-estrogen receptor. A key interplay of the expression of syndecan-2 and metalloproteinase- 9 in breast cancer cells. Mol. Oncol. 2, 223-232
32. Merrell, M., Suarez-Cuervo, C., Harris, K. W., Väänänen, H. K., and Selander, K. S. (2003) Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition. Breast Cancer Res. Treat. 81, 231-241 (Pubitemid 37352460)
33. Peng, J., and Jordan, V. C. (2010) Expression of estrogen receptor α with a Tet-Off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells. Int. J. Oncol. 36, 451-458
34. Filardo, E., Quinn, J., Pang, Y., Graeber, C., Shaw, S., Dong, J., and Thomas, P. (2007) Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148, 3236-3245 (Pubitemid 46997004)
35. Zhong, M., Carney, D. H., Boyan, B. D., and Schwartz, Z. (2011) 17β-Estradiol regulates rat growth plate chondrocyte apoptosis through a mitochondrial pathway not involving nitric oxide or MAPKs. Endocrinology 152, 82-92
36. Revankar, C. M., Mitchell, H. D., Field, A. S., Burai, R., Corona, C., Ramesh, C., Sklar, L. A., Arterburn, J. B., and Prossnitz, E. R. (2007) Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem. Biol. 2, 536-544 (Pubitemid 350011324)
37. Olde, B., and Leeb-Lundberg, L. M. (2009) GPR30/GPER1. Searching for a role in estrogen physiology. Trends Endocrinol. Metab. 20, 409-416
38. 2-vitamin D3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells. J. Steroid Biochem. Mol. Biol. 121, 169-175
39. Kim, H. P., Lee, J. Y., Jeong, J. K., Bae, S. W., Lee, H. K., and Jo, I. (1999) Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae. Biochem. Biophys. Res. Commun. 263, 257-262
40. Marino, M., Distefano, E., Caporali, S., Ceracchi, G., Pallottini, V., and Trentalance, A. (2001) β-Estradiol stimulation of DNA synthesis requires different PKC isoforms in HepG2 and MCF7 cells. J. Cell. Physiol. 188, 170-177 (Pubitemid 32622907)
41. Carey, I., Williams, C. L., Ways, D. K., and Noti, J. D. (1999) Overexpression of protein kinase C-α in MCF-7 breast cancer cells results in differential regulation and expression of αvβ3 and αvβ5. Int. J. Oncol. 15, 127-136
42. Weldon, C. B., McKee, A., Collins-Burow, B. M., Melnik, L. I., Scandurro, A. B., McLachlan, J. A., Burow, M. E., and Beckman, B. S. (2005) PKC- mediated survival signaling in breast carcinoma cells. A role for MEK1- AP1 signaling. Int. J. Oncol. 26, 763-768
43. Jain, S., Chakraborty, G., and Kundu, G. C. (2006) The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C α/c-Src/IκB kinase α/β-dependent prostate tumor progression and angiogenesis. Cancer Res. 66, 6638-6648 (Pubitemid 44085620)
44. Ways, D. K., Kukoly, C. A., deVente, J., Hooker, J. L., Bryant, W. O., Posekany, K. J., Fletcher, D. J., Cook, P. P., and Parker, P. J. (1995) MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J. Clin. Invest. 95, 1906-1915
45. Connolly, J., and Rose, D. (1997) Expression of the invasive phenotype by MCF-7 human breast cancer cells transfected to overexpress protein kinase C-α or the erbB2 proto-oncogene. Int. J. Oncol. 10, 71-76 (Pubitemid 26426657)
46. Tomaskovic-Crook, E., Thompson, E. W., and Thiery, J. P. (2009) Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res. 11, 213
47. Blick, T., Widodo, E., Hugo, H., Waltham, M., Lenburg, M. E., Neve, R. M., and Thompson, E. W. (2008) Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin. Exp. Metastasis 25, 629-642
48. Vincent-Salomon, A., and Thiery, J. P. (2003) Host microenvironment in breast cancer development. Epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res. 5, 101-106 (Pubitemid 36348104)
49. Deng, H., Huang, X., Fan, J., Wang, L., Xia, Q., Yang, X., Wang, Z., and Liu, L. (2010) A variant of estrogen receptor-α, ER-α36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis. Oncol. Rep. 24, 171-176